approved EB-2 (NIW)

Research Fellow

Biomedical Engineering · Egypt · 2022-10-20

Processing Time
278 days
Decision Date
2022-10-20
Location
Arizona
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to leverage her expertise in biomaterials and regenerative tissue engineering to curate novel treatment methods that are minimally harmful and effective for clinical use. Her work focuses on creating molecular drug designs to improve chemotherapy delivery and developing solutions for integrating ligament tissue to treat ACL injuries.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses leading causes of death like cancer and common orthopedic injuries, which has broad implications for U.S. public health and the sports industry.

2 Well-positioned to Advance the Endeavor Met

The petitioner has 7 years of direct research experience and a record of published work cited 60 times by researchers worldwide.

3 Waiver of Job Offer and Labor Certification Met

Given the critical nature of her biomedical research and NIH funding, it was found beneficial to the U.S. to waive the labor certification requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's 7 years of research experience, 3 peer-reviewed journal articles, and 1 conference paper which accumulated 60 citations. The case was supported by 4 expert recommendation letters and evidence of funding from the National Institutes of Health (NIH), satisfying the Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Conference Presentations
Grants
Reference Letters Dependent
Original Contributions
Government Alignment

Similar Cases

Engineer

Materials Science · China

WeGreened EB-2 (NIW) approved
California 6 days 2023-08-02
The petitioner proposes to investigate the biomedical applications of advanced biomaterials and manufacturing technologies to develop tissue substitutes for regenerative medicine. This work aims to create tumor models for cancer study to improve the outcomes of preclinical trials, diagnosis, and treatment.

Research Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved
Massachusetts 11 days 2023-11-03
The petitioner proposes to continue research in the United States focused on tissue engineering and bioadhesive materials. This work involves applying mechanical engineering principles to develop advanced hydrogels, scaffolds, and adhesive devices for regenerative medicine and surgical care. The endeavor aims to address critical challenges in wound healing and trauma recovery by providing innovative medical devices.

Postdoctoral Researcher

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
Belgium 577 days 2025-08-18
The petitioner proposes to develop new regenerative medicine strategies by identifying and designing smart biomaterials. This work focuses on improving treatments for incurable conditions such as chronic wounds, spinal cord injuries, bone and cartilage damage, and various forms of cancer. The research aims to bridge polymer engineering and biomedical applications to advance healthcare solutions.

Research Scientist

Research and Development · Taiwan

WeGreened EB-2 (NIW) approved
California 7 days 2023-05-08
The petitioner proposes to develop large-scale, vascularized bone tissue engineering constructs to optimize drug screening and cell sorting methodologies. This work utilizes mechanical engineering principles to create original solutions for reducing the burden of orthopedic conditions and treating orthopedic trauma.

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2022-10-20.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 278 days
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist